Erste Group upgraded AbbVie (ABBV) to Buy from Hold.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie announces final analysis of Phase 3 MIRASOL trial
- Big Pharma rejoins the mental health field, WSJ says
- AbbVie: Hold Rating Maintained Amid Strong Skyrizi Sales and Valuation Concerns
- AbbVie price target raised to $195 from $165 at Berenberg
- Biotech Alert: Searches spiking for these stocks today